Search results

  1. Acute heart failure

    Everything NICE has said on diagnosing and managing acute heart failure in an interactive flowchart

  2. Acute upper gastrointestinal bleeding

    Everything NICE has said on risk assessment and management of acute upper gastrointestinal bleeding in people 16 years and older in an interactive flowchart

  3. Abortion care

    Everything NICE has said on abortion care in an interactive flowchart.

  4. Cervical cancer

    Everything NICE has said on screening and managing cervical cancer in an interactive flowchart

  5. Cataracts

    Everything NICE has said on cataracts in adults in an interactive flowchart

  6. Induction of labour

    Everything NICE has said on inducing labour in an interactive flowchart

  7. Smoking cessation in secondary care

    Everything NICE has said on helping people to stop smoking in secondary care in an interactive flowchart

  8. Stroke

    Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart

  9. Intermediate care including reablement

    Everything NICE has said on referral and assessment for and delivery of intermediate care including reablement in an interactive flowchart

  10. Influenza

    Everything NICE has said on influenza in an interactive flowchart

  11. Gastrointestinal cancers

    Everything NICE has said on gastrointestinal cancers in an interactive flowchart

  12. Gallstone disease

    Everything NICE has said on diagnosing and managing gallstone disease in adults in an interactive flowchart

  13. Glaucoma

    Everything NICE has said on assessing, treating and managing glaucoma in adults in an interactive flowchart

  14. Generalised anxiety disorder

    Everything NICE has said on managing generalised anxiety disorder in adults in primary, secondary and community care in an interactive flowchart

  15. Harmful sexual behaviour among children and young people

    Everything NICE has said on harmful sexual behaviour among children and young people (under 18s or under 25s with special educational needs or a disability) in an interactive flowchart.

  16. Hearing loss

    Everything NICE has said on hearing loss or impairment in adults in an interactive flowchart

  17. Acutely ill patients in hospital

    Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart

  18. Urogenital conditions

    Everything NICE has said on urogenital conditions in an interactive flowchart

  19. Urinary incontinence in neurological disease

    Everything NICE has said on managing lower urinary tract dysfunction resulting from neurological disease and injury in an interactive flowchart

  20. Sepsis

    Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart

  21. Colorectal cancer

    Everything NICE has said on diagnosing and managing colorectal (bowel) cancer in an interactive flowchart

  22. Rheumatoid arthritis

    Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

  23. Early and locally advanced breast cancer

    Everything NICE has said on diagnosing and treating early and locally advanced breast cancer in an interactive flowchart

  24. Lower urinary tract symptoms in men

    Everything NICE has said on managing lower urinary tract symptoms in men in an interactive flowchart

  25. Cystic fibrosis

    Everything NICE has said on diagnosing and managing cystic fibrosis in an interactive flowchart

  26. Venous thromboembolism

    Everything NICE has said on assessing, diagnosing, treating and reducing the risk of venous thromboembolism in adults in an interactive flowchart

  27. Neurological conditions

    Everything NICE has said on neurological conditions in an interactive flowchart

  28. Shared decision making (KTT23)

    This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .

  29. Chemotherapy dose standardisation (KTT22)

    This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  30. Medicines optimisation in chronic pain (KTT21)

    This document summarises the evidence base on medicines optimisation in chronic pain . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  31. Safer insulin prescribing (KTT20)

    This document summarises the evidence base on safer insulin prescribing . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  32. Multimorbidity and polypharmacy (KTT18)

    This document summarises the evidence base on multimorbidity and polypharmacy . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  33. Anticoagulants, including direct-acting oral anticoagulants (DOACs) (KTT16)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on anticoagulants , including direct-acting oral anticoagulants (DOACs). It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  34. Biosimilar medicines (KTT15)

    The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  35. Wound care products (KTT14)

    This document summarises the evidence base on wound care products . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  36. Non-steroidal anti-inflammatory drugs (KTT13)

    The key therapeutic topic non-steroidal anti-inflammatory drugs has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  37. Antipsychotics in people living with dementia (KTT7)

    This document summarises the evidence base on antipsychotics in people living with dementia . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  38. Hypnotics (KTT6)

    This document summarises the evidence base on hypnotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  39. Asthma: medicines safety priorities (KTT5)

    This document summarises the evidence base on asthma: medicines safety priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  40. Lipid-modifying drugs (KTT3)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  41. Type 2 diabetes mellitus: medicines optimisation priorities (KTT12)

    This document summarises the evidence base on type 2 diabetes mellitus: medicines optimisation priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .